HEIDELBERG, Allemagne–(BUSINESS WIRE)–Novaliq GmbH, société pharmaceutique de spécialité qui possède une plateforme d’administration de médicaments d’avant-garde, transformant des médicaments peu solubles en produits ophtalmologiques efficaces, a annoncé aujourd’hui avoir obtenu des résultats positifs de Phase 2 dans le cadre de l’évaluation de CyclASol®, solution à base de cyclosporine A transparente et sans agents de conservation, auprès de 207 patients souffrant d’une sécheresse oculaire m
Category: News
Researchers uncover two factors that play crucial role in chronic autoimmune disorders
Researchers from Schepens Eye Research Institute of Massachusetts Eye and Ear have uncovered two factors responsible for the chronic, lifelong nature of autoimmune disorders, which tend to “flare up” intermittently in affected patients.
Argus Vision Enters Partnership with PogoTec
LAS VEGAS–(BUSINESS WIRE)–January 4, 2017 – Taiwan-based Argus Vision today announced a strategic partnership with PogoTec to manufacture a new line of sun wear equipped with the PogoTrack™ wearable technology platform.
How does the brain control appetite?
Energy balance between energy intake and expenditure in our bodies is important for maintaining energy homeostasis to keep our bodies functioning properly. The appetite determines how much we eat, the energy intake, by communication between the brain a…
Gun violence is least-researched and underfunded cause of death, study shows
Funding and publication of gun violence research are disproportionately low compared to other leading causes of death in the United States, according to new research from the Icahn School of Medicine at Mount Sinai published online today in the Journal…
A closer look at the eye
Researchers at the University of Rochester Medical Center have developed a new imaging technique that could revolutionize how eye health and disease are assessed.
Zinc: A surprise target in regenerating the optic nerve after injury
For more than two decades, researchers have tried to regenerate the injured optic nerve using different growth factors and/or agents that overcome natural growth inhibition.
Use of Rescue Aflibercept Linked With Improved Vision After DME Therapy
Intravitreal aflibercept injections are associated with better visual acuity in patients who have lost some of their vision after macular laser photocoagulation for diabetic macular edema (DME), according to a post hoc analysis of two randomized clinic…
3M Completes Sale of its Safety Prescription Eyewear Business
ST. PAUL, Minn.–(BUSINESS WIRE)–3M announced today that it has completed the sale of its safety prescription eyewear business to HOYA Vision Care, a global leader in the eyeglass lens industry. The safety prescription eyewear business provides a comprehensive line of frames, prescription lenses, and premium coating options in a custom-made solution. The business has annual global sales of approximately $45 million. The safety prescription eyewear business was part of 3M’s Personal Safety Divi
RightEye vision performance assessments to be conducted at MLB and USA Baseball’s Prospect Development Pipeline events
WASHINGTON–(BUSINESS WIRE)–#CES–RightEye selected to provide baseline performance vision screenings for elite amateur baseball players at all MLB and USA Baseball Prospect Development Pipeline events.
BioTime and Subsidiary Cell Cure Neurosciences Establish Innovative Cell Therapy Manufacturing Center in Jerusalem, Israel
ALAMEDA, Calif. & JERUSALEM–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT: BTX and TASE: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, and its majority-owned subsidiary, Cell Cure Neurosciences Ltd, today dedicated a new, 800 square meter (8,600 square feet), state-of-the-art, cGMP manufacturing center located in the Jerusalem Bio Park on the campus of Hadassah University Hospital in Jerusalem. The new manufacturing center, in
Inotek Announces Top-line Results for MATrX-1, First Phase 3 Trial of Trabodenoson for Glaucoma
LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) today announced top-line results of MATrX-1, the first pivotal Phase 3 trial of trabodenoson for glaucoma.
New imaging technique could revolutionize assessment of eye health and disease
Researchers at the University of Rochester Medical Center have developed a new imaging technique that could revolutionize how eye health and disease are assessed.
Retinal Migraine: Causes, Symptoms, and Treatment
Retinal migraine is an eye condition that affects some people who get migraine. Visual disturbances develop in one eye, followed by migraine symptoms.
Early Cell Loss After Corneal Transplant Due to Eye Bank Miscount
Most very early cell loss after corneal transplant isn’t due to surgical technique but to overestimated cell counts by eye banks, new research from France suggests. Reuters Health Information
Eyes as a Window to Your Health: RightEye Unveils New Assessments for Healthcare and Vision Performance at CES 2017
LAS VEGAS & WASHINGTON–(BUSINESS WIRE)–#CES–RightEye to unveil new assessments for healthcare and vision performance at CES 2017, where it will exhibit at Unveiled in booth 118, and at CES in booth 43035 in the Sands Convention Center.
Intravitreal Dexamethasone Improves Uveitic CME
An intravitreal dexamethasone implant may help patients who experience persistent CME despite control of ocular inflammation, a new study has found. Medscape Medical News
Cost-effectiveness of Follow-up Efforts After Cataract Surgery
In low- and middle-income countries, a reminder on the day of cataract surgery is the most cost-effective way to help ensure a follow-up visit, rather than making phone calls or offering transportation subsidies, researchers report. Reuters Health In…
False Positives Common With LabCorp Zika Testing, FDA Warns
The ZIKV Detect test for virus antibodies always requires confirmation. A higher-than-expected rate of false positives underlines the need for double-checking. News Alerts
Eye to the Future: 2017 Ophthalmology Compensation Trends
Baby boomers are swelling the patient ranks, offsetting reimbursement declines. But will increasing volume push already overworked practitioners to the edge? Medscape Business of Medicine